 Presence PAF-acether stool patients pouch ileoanal anastomosis pouchitis Platelet-activating factor endogenous phospholipid wide variety inflammatory cells Platelet-activating factor induces severe pathological changes various organs numerous potent effects bowel necrosis Pouchitis understood complication ileoanal pouch anastomosis patients surgery ulcerative colitis aim study ileal fecal platelet-activating factor lyso platelet-activating factor contents normal volunteers patients terminal ileostomy patients ileoanal anastomosis patients presence ulcerations reservoir Fecal samples platelet-activating factor platelet aggregation assay material platelet-activating factor following inhibition platelet aggregation specific platelet-activating factor receptor antagonist BN IHB Le Plessis Robinson France abolition platelet aggregation incubation phospholipase lipase retention time high-performance liquid chromatography Stool platelet-activating factor content nanograms gram stool mean patients pouchitis ng/g patients normal reservoir ng/g terminal ileostomy ng/g healthy controls ng/g stool Lyso platelet-activating factor nanograms gram stool patients pouchitis ng/g patients normal reservoir ng/g stool terminal ileostomy ng/g healthy volunteers ng/g patients ileoanal anastomosis pouchitis platelet-activating factor production inflammation ulcerations reservoir